SAVA
Cassava Sciences, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website cassavasciences.com
- Employees(FY) 26
- ISIN US14817C1071
Performance
+9.24%
1W
+1.32%
1M
+18.66%
3M
+29.21%
6M
+16.13%
YTD
+34.05%
1Y
Profile
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.
Technical Analysis of SAVA 2024-11-13
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-07 07:55
- 2024-11-06 18:55
- 2024-10-31 08:30
- 2024-10-30 20:30
- 2024-10-30 09:47
- 2024-10-17 09:19
- 2024-10-09 08:29
- 2024-09-27 15:36
Cassava Sciences agrees to $40M SEC fine over Alzehimer's claims(Yahoo Finance Video)
- 2024-09-26 22:10
- 2024-09-26 18:15
Cassava Sciences Resolves SEC Investigation(GlobeNewswire)
- 2024-09-24 08:30
- 2024-09-23 20:30
- 2024-09-09 08:30
Cassava Sciences Names Rick Barry as Chief Executive Officer(GlobeNewswire)
- 2024-09-08 20:30
Cassava Sciences Names Rick Barry as Chief Executive Officer(Globenewswire)
- 2024-09-03 08:31
- 2024-09-02 20:31
- 2024-08-17 10:44
- 2024-08-16 20:22
7 Best Debt Free Stocks To Buy(Insidermonkey)
- 2024-08-10 09:09
Cassava Sciences, Inc. (NASDAQ:SAVA): Is Breakeven Near?(Simply Wall St.)
- 2024-08-08 08:00
- 2024-08-07 20:00
- 2024-08-05 22:00
Cassava Sciences News: Why Is SAVA Stock Trending Today?(Investorplace)
- 2024-08-05 09:01
- 2024-08-04 21:01
- 2024-08-01 08:30
- 2024-07-31 20:30
- 2024-07-30 08:15
- 2024-07-29 20:15
- 2024-07-17 08:00
- 2024-07-17 00:26
Page 1 of 6
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.